Real-time ultrasonography-computed tomography fusion imaging for staging of hepatic metastatic involvement in patients with colorectal cancer: Initial results from comparison to US seeing separate CT images and to multidetector-row CT alone

Investigative Radiology

Volumn 45, Issue 8, 2010, Pages 491-501

  Stang, Axel ^a   Keles, Handan ^a   Hentschke, Suna ^a   Seydewitz, Cay ^a   Keuchel, Martin ^a   Pohland, Christopher ^a   Dahlke, Joachim ^a   Weilert, Hauke ^a   Wessling, Johannes ^b   Malzfeldt, Ernst ^a  

^a ASKLEPIOS KLINIK ALTONA   (Germany)

^b UNIVERSITY HOSPITAL MÜNSTER   (Germany)

Author keywords

Colorectal cancer; Computed tomography; Image fusion; Liver metastases; Ultrasonography

Indexed keywords

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER STAGING; CANCER SURGERY; CLINICAL ARTICLE; COLORECTAL CANCER; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LIVER INJURY; LIVER METASTASIS; MALE; METASTASIS; MULTIDETECTOR COMPUTED TOMOGRAPHY; PRIMARY TUMOR; PRIORITY JOURNAL; PROSPECTIVE STUDY;

EID: 77954760853     PISSN: 00209996     EISSN: 15360210     Source Type: Journal    
DOI: 10.1097/RLI.0b013e3181ddd3da     Document Type: Article

References (65)

1. Garden OJ, Rees M, Poston GJ, et al. Guidelines for resection of colorectal cancer liver metastases. Gut. 2006;55(suppl 3):iii1-iii8.
2. Stang A, Fischbach R, Teichmann W, et al. A systematic review on the clinical benefit and role of radiofrequency ablation as treatment of colorectal liver metastases. Eur J Cancer. 2009;45:1748-1756.
3. Pawlick TM, Schulick RD, Choti MA. Expanding criteria for resectability of colorectal liver metastases. Oncologist. 2008;13:51-64.
4. Tomlinson JS, Janargin WR, DeMatteo RP, et al. Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol. 2007;25:4575-4580.
5. Van Erkel AR, Pijl ME, van den Berg-Huysmans AA, et al. Hepatic metastases in patients with colorectal cancer: relationship between size of metastases, standard of reference, and detection rates. Radiology. 2002;224: 404-409.
6. Elias D, Sideris L, Pocard M, et al. Incidence of unsuspected and treatable metastatic disease associated with operable colorectal liver metastases discovered only at laparotomy. Ann Surg Oncol. 2005;12:298-302.
7. Ong KO, Leen E. Radiological staging of colorectal metastases. Surg Oncol. 2007;16:7-14.
8. Karhunen PJ. Benign hepatic tumors and tumor like conditions in men. J Clin Pathol. 1986;39:183-188.
9. Lim GH, Koh DC, Cheong WK, et al. Natural history of small, "indeterminate" hepatic lesions in patients with colorectal cancer. Dis Colon Rectum. 2009;52:1487-1491.
10. Jang HJ, Lim HK, Lee WJ, et al. Small hypoatteuating lesions on single-phase helical CT in preoperative patients with gastric and colorectal cancer: prev alence, significance, and differentiating features. J Comput Assist Tomogr. 2002;26:718-724.
11. Schwartz LH, Gandras EJ, Colangelo SM, et al. Prevalence and importance of small hepatic lesion found at CT in patients with cancer. Radiology. 1999; 210:71-74.
12. Robinson PJ, Arnold P, Wilson D. Small indeterminate lesions on CT of the liver: a follow-up study of stability. Br J Radiol. 2003;76:866-874.
13. Bipat S, van Leeuwen MS, Comans EF, et al. Colorectal liver metastases: CT, MR imaging, and PET for diagnosis-meta-analysis. Radiology. 2005;237: 123-131.
14. Motosugi U, Ichikawa T, Nakajima H, et al. Imaging of small hepatic metastases of colorectal carcinoma: how to use superparamagnetic iron oxide-enhanced magnetic resonance imaging in the multidetector-row computed tomography age? J Comput Assist Tomogr. 2009;33:266-272.
15. Winterer JT, Kotter E, Ghanem N, et al. Detection and characterization of benign focal liver lesions with multislice CT. Eur Radiol. 2006;16:2427-2443.
16. Haider MA, Amitai MM, Rappaport DC, et al. Multi-detector row helical CT in preoperative assessment of small (< or = 1.5 cm) liver metastases: is thinner collimination better? Radiology, 2002, 225, 137-142
17. Abdelmoumene A, Chevalier P, Challaron M, et al. Detection of liver metastases under 2 cm: comparison of different acquisition protocols in four row multidetector-CT (MDCT). Eur Radiol. 2005;15:1881-1887.
18. Kim KW, Kim AY, Kim TK, et al. Small (<2 cm) hepatic lesions in colorectal cancer patients: detection and characterization on mangafodipir trisodium-enhanced MRI. Am J Roentgenol. 2004. 182. 1233-1240.
19. Mainenti PP, Mancini M, Mainolfi C, et al. Detection of colo-rectal liver metastases: prospective comparison of contrast enhanced US, multidetector CT, PET/CT, and 1,5 Tesla MR with extracellular and reticulo-endethelial cell specific contrast agents. Abdom Imaging. 2009 Jun 27. [Epub ahead of print]
20. Onishi H, Murakami T, Kim T, et al. Hepatic metastases: detection with multi-detector raw CT, SPIO-enhanced MR imaging, and both techniques combined. Radiology. 2006;239:131-138.
21. Lee HY, Lee JM, Kim SH, et al. Detection and characterization of focal hepatic lesions: comparative study of MDCT and gadobendate dimeglumine-enhanced MR imaging. Clin Imaging. 2008;32:287-295.
22. Ward J, Robinson PJ, Guthrie JA, et al. Liver metastases in candidates for hepatic resection: comparison of helical CT and gadolinium-and SPIO-enhanced MR imaging. Radiology. 2005;237:170-180.
23. Reggae D, Campanelli D, Anselmetti GC, et al. Diagnostic accuracy of portal-phase CT and MRI with mangafodipir trisodium in detecting liver metastases from colorectal carcinoma. Clin Radiol. 2006;61:338-337.
24. Rappeport ED, Loft A, Berthelsen AK, et al. Contrast-enhanced FDG-PET/CT vs. SPIO-enhanced MRI vs. FDG-PET vs. CT in patients with liver metastases from colorectal cancer: a prospective study with intraoperative confirmation. Acta Radiol. 2007;48:369-378.
25. Scott DJ, Guthrie JA, Arnold P, et al. Dual phase helical CT versus portal venous phase CT for the detection of colorectal metastases: correlation with intra-operative sonography, surgical and pathological findings. Clin Radiol. 2001;56:235-242.
26. Valls C, Anda E, Sanchez A, et al. Hepatic metastases from colorectal cancer: preoperative assessment of resectability with helical CT. Radiology. 2001; 218:55-60.
27. Bartalozzi C, Donati F, Cioni D, et al. Detection of colorectal liver metatases: a prospective multicenter trial comparing unenhanced MRI, MnDPDP-en-hanced MRI, and spiral CT. Eur Radiol. 2004;14:14-20.
28. Brick SH, Hill MC, Lande IM. The mistaken or indeterminate CT diagnosis of hepatic metastases: the value of sonography. Am J Roentgenol. 1987;148: 723-726.
29. Eberhardt SC, Choi PH, Bach AM, et al. Utility of sonography for small hepatic lesions found on computed tomography in patients with cancer. J Ultrasound Med. 2003;22:345-346.
30. Stang A. Sonographic characteristics of a dermoid cyst\correlation with CT by use of real-time image fusion. Ultraschall Med. 2006;27:211-213.
31. Minami Y, Chung H, Kudo, et al. Radiofrequency ablation of hepatocellular carcinoma: value of virtual CT sonography with magnetic navigation. Am J Roentgenol. 2008;190:W335-W341.
32. Kitada T, Murakami T, Kuzushita N, et al. Effectiveness of real-time virtual sonography-guided ablation treatment for patient with hepatocellular carcinomas. Hepatol Res. 2008;38:565-571.
33. Tatsugami F, Matsuki M, Nakai G, et al. Hepatic computed tomography for simultaneous depiction of hepatocellular carcinoma, intrahepatic portal veins, and hepatic veins in real-time virtual sonography: initial experience. J Ultrasound Med. 2007;26:1065-1069.
34. Kawasoe H, Eguchi Y, Mizuta T, et al. Radiofrequency ablation with the real-time virtual sonography system for treating hepatocellular carcinoma difficult to detect by ultrasonography. J Clin Biochem Nutr. 2007;40: 66-72.
35. Krucker J, Xu S, Glossop N, et al. Electromagnetic tracking for thermal ablation and biopsy guidance: clinical evaluation of spatial accuracy. J Vasc Interv Radiol. 2007;18:1141-1150.
36. Hirooka M, Iuchi H, Kumagi T, et al. Virtual sonographic radiofrequency ablation of hepatocellular carcinoma visualized on CT but not on conventional sonography. Am J Roentgenol. 2006;186:255-260.
37. Birth M, Ibler P, Hildebrand P, et al. Ultrasound-guided interventions using magnetic field navigation: first experiences with Ultra-Guide 2000 under operative conditions. Ultraschall Med. 2003;24:90-95.
38. Crocetti L, Lencioni R, DeBeni S, et al. Targeting liver lesions for radiofrequency ablation: an experimental feasibility study using a CT-US fusion imaging system. Invest Radiol. 2008;43:33-39.
39. Jung EM, Schreyer AG, Schacherer D, et al. New real-time image fusion technique for characterization of tumor vascularization and tumor perfusion of liver tumors with contrast-enhanced ultrasound, spiral CT or MRI: first results. Clin Hemorheol Microcirc. 2009;43:57-69.
40. Kruskal JB, Kane RA. Intraoperative US of the liver: techniques and clinical applications. Radiographics. 2006;26:1067-1084.
41. DeLong ER, DeLong DM, Clark-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics. 1988;44:837-845.
42. Hanley JA, McNeil BJ. A method of comparing the areas under receiver operating characteristic curves derived from the same cases. Radiology. 1983;148:839-843.
43. Lind SE, Singer DE. Diagnosing liver metastases: a Bayesian analysis. J Clin Oncol. 1986;4:379-388.
44. Kinkel K, Ying L, Both M, et al. Detection of hepatic metastases from cancers of the gastrointestinal tract by using noninvasive imaging methods (US, CT, MR imaging, PET): a meta-analysis. Radiology. 2002;224:748-756.
45. Teefey SA, Hildeboldt CC, Dehdashti F, et al. Detection of primary hepatic malignancy in liver transplant candidates: prospective comparison of CT, MR imaging, US, and PET. Radiology. 2003;226:533-542.
46. Ralls PW, Jeffrey RB, Kane RA, et al. Ultrasonography. Gastroenterol Clin N Am. 2002;31:801-825.
47. Claudon M, Cosgrove D, Albrecht T, et al. Guidelines and good clinical practice recommendations for contrast enhanced ultrasound (CEUS)\update 2008. Ultraschall Med. 2008;29:28-44.
48. Dai Y, Chen MH, Yin SS, et al. Focal liver lesions. Can Sonovue-enhanced ultrasound be used to differentiate malignant from benign lesions? Invest Radiol. 2007;42:596-603.
49. Wein W, Brunke S, Khamene A, et al. Automatic CT-ultrasound registration for diagnostic imaging and image-guided intervention. Med Image Anal. 2008;12:577-585.
50. Molloy JA, Oldham SA. Benchmarking a novel ultrasound-CT fusion system for respiratory motion management in radiotherapy: assessment of patio-temporal characteristics and comparison to 4DCT. Med Phys. 2008;35:291-300.
51. Ba-Ssalamah A, Uffmann M, Saini S, et al. Clinical value of MRI liver-specific contrast agents: a tailored examination for a confident non-invasive diagnosis of focal liver lesions. Eur Radiol. 2009;19:342-357.
52. Elsayes KM, Leydendecker JR, Menias CO, et al. MRI characterization of 124 CT-indeterminate focal hepatic lesions: evaluation of clinical utility. HPB (Oxford). 2007;9:208-215.
53. Lee DH, Kim SH, Lee JM, et al. Diagnostic performance of multidetector row computed tomography, supermagnetic iron oxide-enhanced magnetic resonance imaging, and dual-contrast magnetic resonance imaging in predicting the appropriateness of a transplant recipient based on Milan criteria: correlation with histopathological findings. Invest Radiol. 2009;44:311-321.
54. Ichikawa T, Saito K, Tanimoto A, et al. Detection and characterization of focal liver lesions: a Japanese phase III, multicenter comparison between gadoxetic acid disodium-enhanced magnetic resonance imaging and contrast-enhanced computed tomography predominately in patients with hepatocellular carcinoma and chronic liver disease, Invest Radiol. 2010; 45, 133-141
55. Lichy MP, Achoff P, Plathow C, et al. Tumor detection by diffusion-weighted MRI and ADC-mapping\initial clinical experiences in comparison to PET-CT. Invest Radiol. 2007;42:605-613.
56. Erturk SM, Ichikawa T, Sano K, et al. Diffusion-weighted magnetic resonance imaging for characterization of focal liver masses: impact of parallel imaging (SENSE) and b value. J Comp Assist Tomogr. 2008;32:865-871.
57. Runge VM. Advances in magnetic resonance. Invest Radiol. 2009;44:808-812.
58. Yoon MA, Kim SH, Park HS, et al. Value of dual contrast at 3.0 T in differentiating well-differentiated hepatocellular carcinoma from dysplatic nodules. Preliminary results of multivariate analysis. Invest Radiol. 2009;44: 641-649.
59. Zech CJ, Herrmann KA, Dietrich O, et al. Black-blood diffusion-weighted EPI acquisition of the liver with parallel imaging. Comparison with a standard T2-weighted sequence for detection of focal liver lesions. Invest Radiol. 2008;43:261-266.
60. Takahara T, Kwee TC, van Leeuwen MS, et al. Diffusion-weighted magnetic resonance imaging of the liver using tracking only navigator echo: feasibility study. Invest Radiol. 2010;45:57-63.
61. Sun HY, Lee JM, Shin CI, et al. Gadoxetic acid-enhanced magnetic resonance imaging for small hepatocellular carcinomas (<2 cm in diameter) from arterial enhancing pseudolesions. Special emphasis on hepatobiliary imaging Invest Radiol. 2010, 45, 96-103
62. Dale BM, Braithwaite AC, Boll DT, et al. Field strength and diffusion encoding technique affect the apparent diffusion coefficient measurements in diffusion-weighted imaging in the abdomen. Invest Radiol. 2010;45:104-108.
63. Hammerstingl R, Adam G, Ayuso JR, et al. Comparison of 1.0 M gadobutrol and 0.5 M gadopentetate dimeglumine-enhanced magnetic resonance imaging in five hundred seventy-two patients with known or suspected liver lesions: results of a multicenter, double-blind, interindividual, randomized clinical phase-III trial. Invest Radiol. 2009;44:168-176.
64. Zech GJ, Grazioli L, Jonas E, et al. Health-economic evaluation of three imaging strategies in patients with suspected colorectal liver metastases: Gd-EOB-DTPA-enhanced MRI vs. extracellular contrast media-enhanced MRI and 3-phase MDCT in Germany, Italy and Sweden. Eur Radiol. 2009;19(suppl 3):S753-S763.
65. Titu LV, Breen DJ, Nicholson AA, et al. Is routine magnetic resonance imaging justified for the early detection of resectable liver metastases from colorectal cancer? Dis Colon Rectum. 2006;49:810-815.